A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression
OBJECTIVE: The medicinal plants Rhodiola rosea L. (rhodiola, golden root) and Crocus sativus L. (saffron) have been shown separately to induce significant effects in depression. The objective of this study was to assess a fixed combination of rhodiola and saffron in mild–moderate depression. METHODS...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049049/ https://www.ncbi.nlm.nih.gov/pubmed/30034237 http://dx.doi.org/10.2147/NDT.S169575 |
_version_ | 1783340211847036928 |
---|---|
author | Bangratz, Marie Ait Abdellah, Samira Berlin, Aurélie Blondeau, Claude Guilbot, Angèle Dubourdeaux, Michel Lemoine, Patrick |
author_facet | Bangratz, Marie Ait Abdellah, Samira Berlin, Aurélie Blondeau, Claude Guilbot, Angèle Dubourdeaux, Michel Lemoine, Patrick |
author_sort | Bangratz, Marie |
collection | PubMed |
description | OBJECTIVE: The medicinal plants Rhodiola rosea L. (rhodiola, golden root) and Crocus sativus L. (saffron) have been shown separately to induce significant effects in depression. The objective of this study was to assess a fixed combination of rhodiola and saffron in mild–moderate depression. METHODS: In this observational study conducted with general practitioners (GPs), 45 adults (aged 18–85 years) suffering from mild or moderate depression (International Statistical Classification of Diseases and Related Health Problems 10th Revision definition) and reaching a score on the Hamilton Rating Scale for Depression of 8–18 were supplemented with a combination of rhodiola and saffron extracts (one tablet, 154 mg of rhodiola and 15 mg of saffron; recommended dose two tablets per day for 6 weeks). RESULTS: After 6 weeks (D42) of supplementation, Hamilton Rating Scale for Depression scores (primary outcome) decreased significantly by 58%±28.5% (from 13.6±2.3 at D0 to 5.6±3.8 at D42, P<0.0001; n=41). Score improvement was reported in 85.4% of patients. A significant drop in both Hospital Anxiety and Depression Scale anxiety and depression scores was also observed at D42, the decrease being significant from 2 weeks of supplementation. At the end of the study, both GPs and patients deemed there was a significant improvement in depression (Clinical Global Impression – improvement and Patient Global Impression of Change). Safety was excellent, and no serious adverse effects were recorded. CONCLUSION: Results of this observational study performed in primary care suggest that the combination of rhodiola and saffron tested could be useful for the management of mild–moderate depression and improve depressive and anxiety symptoms. A double-blind placebo-controlled study is needed to confirm these results. |
format | Online Article Text |
id | pubmed-6049049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60490492018-07-20 A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression Bangratz, Marie Ait Abdellah, Samira Berlin, Aurélie Blondeau, Claude Guilbot, Angèle Dubourdeaux, Michel Lemoine, Patrick Neuropsychiatr Dis Treat Original Research OBJECTIVE: The medicinal plants Rhodiola rosea L. (rhodiola, golden root) and Crocus sativus L. (saffron) have been shown separately to induce significant effects in depression. The objective of this study was to assess a fixed combination of rhodiola and saffron in mild–moderate depression. METHODS: In this observational study conducted with general practitioners (GPs), 45 adults (aged 18–85 years) suffering from mild or moderate depression (International Statistical Classification of Diseases and Related Health Problems 10th Revision definition) and reaching a score on the Hamilton Rating Scale for Depression of 8–18 were supplemented with a combination of rhodiola and saffron extracts (one tablet, 154 mg of rhodiola and 15 mg of saffron; recommended dose two tablets per day for 6 weeks). RESULTS: After 6 weeks (D42) of supplementation, Hamilton Rating Scale for Depression scores (primary outcome) decreased significantly by 58%±28.5% (from 13.6±2.3 at D0 to 5.6±3.8 at D42, P<0.0001; n=41). Score improvement was reported in 85.4% of patients. A significant drop in both Hospital Anxiety and Depression Scale anxiety and depression scores was also observed at D42, the decrease being significant from 2 weeks of supplementation. At the end of the study, both GPs and patients deemed there was a significant improvement in depression (Clinical Global Impression – improvement and Patient Global Impression of Change). Safety was excellent, and no serious adverse effects were recorded. CONCLUSION: Results of this observational study performed in primary care suggest that the combination of rhodiola and saffron tested could be useful for the management of mild–moderate depression and improve depressive and anxiety symptoms. A double-blind placebo-controlled study is needed to confirm these results. Dove Medical Press 2018-07-13 /pmc/articles/PMC6049049/ /pubmed/30034237 http://dx.doi.org/10.2147/NDT.S169575 Text en © 2018 Bangratz et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Bangratz, Marie Ait Abdellah, Samira Berlin, Aurélie Blondeau, Claude Guilbot, Angèle Dubourdeaux, Michel Lemoine, Patrick A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
title | A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
title_full | A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
title_fullStr | A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
title_full_unstemmed | A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
title_short | A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
title_sort | preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049049/ https://www.ncbi.nlm.nih.gov/pubmed/30034237 http://dx.doi.org/10.2147/NDT.S169575 |
work_keys_str_mv | AT bangratzmarie apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT aitabdellahsamira apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT berlinaurelie apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT blondeauclaude apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT guilbotangele apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT dubourdeauxmichel apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT lemoinepatrick apreliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT bangratzmarie preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT aitabdellahsamira preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT berlinaurelie preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT blondeauclaude preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT guilbotangele preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT dubourdeauxmichel preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression AT lemoinepatrick preliminaryassessmentofacombinationofrhodiolaandsaffroninthemanagementofmildmoderatedepression |